Nabila Rabahi

Suggest Changes

Writes About:

Learn More
BACKGROUND/AIMS To assess the benefit of the UDCA-budesonide combination in association with mycophenolate mofetil (MMF) in patients with primary biliary cirrhosis (PBC) at high risk of developing(More)
  • 1